Medicine and Dentistry
Acute Kidney Injury
11%
Adverse Event
8%
Adverse Outcome
12%
Artificial Respiration
15%
Assisted Circulation
22%
Bleeding
6%
Cardiogenic Shock
21%
Chronic Obstructive Pulmonary Disease
8%
Cohort Analysis
63%
Continuous Positive Airway Pressure
7%
COVID-19
43%
Disease
8%
Elderly Patient
7%
Extracorporeal
17%
Extracorporeal Membrane Oxygenation
22%
Frailty
17%
Functional Status
9%
Heart Arrest
15%
Heart Failure
6%
Hemodynamic
7%
Hydrocortisone
7%
Hypoxia
7%
Intensive Care
45%
Intensive Care Medicine
12%
Intensive Care Unit
100%
Isotopes of Calcium
7%
Life Sustaining Treatment
9%
Low Drug Dose
8%
Mortality Rate
15%
Nonsteroid Antiinflammatory Agent
7%
Observational Study
22%
Odds Ratio
6%
Out of Hospital Cardiac Arrest
43%
Perforated Ulcer
5%
Placebo
11%
Platelet
6%
Population
6%
Quality of Life
9%
Randomized Clinical Trial
9%
Renal Replacement Therapy
11%
Resuscitation
22%
Return of Spontaneous Circulation
9%
SAPS II
11%
Sepsis
8%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Systematic Review
15%
Thrombocyte Aggregation
6%
Thrombocyte Function
12%
Triage
6%
Vascular Access
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
8%
Adverse Outcome
7%
Atrial Fibrillation
5%
Bisphosphonic Acid Derivative
7%
Cardiogenic Shock
5%
Case-Control Study
19%
Chronic Obstructive Lung Disease
7%
Cohort Study
38%
Comorbidity
15%
Coronavirinae
8%
Disease
13%
Glucocorticoid
11%
Heart Failure
7%
Hydrocortisone
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Hypoxia
7%
Infection
6%
Mortality Rate
9%
Multiple Sclerosis
7%
Non-Steroidal Anti-Inflammatory Drug
7%
Observational Study
5%
Pharmacokinetics
7%
Piperacillin
7%
Placebo
10%
Replacement Therapy
10%
Respiratory Failure
5%
SARS Coronavirus
13%
Statin (Protein)
7%
Subarachnoid Hemorrhage
7%
Venous Thromboembolism
15%
Nursing and Health Professions
Artificial Respiration
5%
Cohort Analysis
18%
Comorbidity
8%
Confidence Interval
7%
Disease
5%
Intensive Care
33%
Intensive Care Unit
40%
Mortality Rate
8%
Odds Ratio
5%
Rate Ratio
5%